Valmet Corp · OMXHEX:VALMT

Valmet — Non-Deal Roadshow (2026)

39 slides from Valmet's roadshow presentation, 2026

  1. Slide 1: Valmet improves the performance of industrial assets across the lifecycle

    INTERNAL Valmet improves the performance of industrial assets across the lifecycle Valmet Roadshow presentation Q2/2026

  2. Slide 2: Valmet in brief: A global platform for growth

    Valmet in brief: A global platform for growth Key figures for 2025 Valmet’s global presence EMEA 10,469 employees EUR 5,197m EUR 620m China Net sales Comparable EBITA 2,284 employees North America 2,268 employees 11.9% 18,500 Comparable EBITA Employees globally margin Asia-Pacific 1,719 employees La

  3. Slide 3: Valmet improves the performance of industrial assets across the lifecycle

    Valmet improves the performance of industrial assets across the lifecycle WE HELP CUSTOMERS TO: Delivered through lifecycle 2030 TARGETS services, upgrades and • Run their operations more automation reliably 5% Organic growth • Produce more efficiently WHAT THIS MEANS FOR VALMET • Use fewer resource

  4. Slide 4: Market leader serving customers in global process industries

    Market leader serving customers in global process industries Net sales Comparable EBITA Net sales Comparable EBITA EUR 3,716 million 10.3% EUR 1,481 million 19.6% Biomaterial Process Solutions and Performance Services Solutions Over one-third of global paper & board production runs Strong positions

  5. Slide 5: Proven track-record of growth in volumes and profitability

    Proven track-record of growth in volumes and profitability Orders received (EUR billion) Net sales (EUR billion) Comparable EBITA (EUR million and % of net sales) 12% 10% 8% 5,8 5,5 5,4 5,2 5,0 5,2 5,0 5,1 5,2 5,3 6% 4,7 619 609 620 612 4,0 3,9 3,7 3,7 533 3,3 3,3 3,5 3,7 4% 2,9 3,1 3,0 2,9 3,1 429

  6. Slide 6: Process Performance Solutions – Strong growth and profitability record

    Process Performance Solutions – Strong growth and profitability record Responsible for ~50% of Valmet’s comparable EBITA Net sales development, EUR million ◼ Automation Solutions Systematic portfolio expansion ◼ Flow Control and continuous investment into technology and digitalization 1,500 Organic

  7. Slide 7: Lead the Way will take Valmet to a new level of performance

    STRATEGY 2030 Lead the Way will take Valmet to a new level of performance ... elevated to next level of performance More focused, bolder strategy Differentiated, competitive businesses…  Four strong fundamentals  Fewer, more ambitious strategic initiatives World-leading technology  Disciplined ca

  8. Slide 8: Appendix

    Appendix Valmet >

  9. Slide 9: Strategy

    Strategy Valmet >

  10. Slide 10: Lead the Way: Transforming industries towards a regenerative tomorrow

    Lead the Way Transforming industries towards a regenerative tomorrow Process Performance Biomaterial Solutions Solutions and Services UNLOCKING RESOURCE EFFICIENCY ADVANCING CIRCULARITY Leading lifecycle value, reliability Seamless lifecycle approach to and customer experience grow in services and t

  11. Slide 11: Lead the Way strategy aims to reshape mindset and culture

    Lead the Way strategy aims to reshape mindset and culture.. Technology first → Customer success first Separated projects and services → Lifecycle-centered approach Matrixed and complex → Accountable and empowered Continuous improvement → Bold multi-year targets 100+ initiatives based on Must-Wins →

  12. Slide 12: We have strong market positions globally

    We have strong market positions globally Biomaterial solutions Biomaterial services Process Performance Solutions Board and Pulp and Flow Control Automation Tissue Energy Solutions Market position Market position Market position Market position Market position Pulp Energy Pulp and Energy and #1 #1–2

  13. Slide 13: 2030 financial targets reflect a step change in ambition

    2030 financial targets reflect a step change in ambition 5% 15% 20% <50% Organic net sales growth Comparable EBITA Comparable ROCE Gearing (CAGR) over the cycle margin Comparable ROCE before taxes = (profit before taxes + interests and other financial expenses +/- items affecting comparability) / (b

  14. Slide 14: Clear capital allocation priorities supporting long-term value creation

    Clear capital allocation priorities supporting long-term value creation Organic growth Biomaterials Solutions and Services 1 Funding organic growth, focusing on ROCE and competitiveness Organic mandate: Grow services and drive cost competitiveness M&A potential: Limited, mainly in Biomaterial Servic

  15. Slide 15: Global Supply plays a key role in our efficiency initiatives

    Global Supply plays a key role in our efficiency initiatives - From local, fragmented operations to a globally optimized supply model Facts on Global Supply We are making a step-change in cost competitiveness ▪ 4,432 employees ▪ 37 production sites ▪ 21,000 suppliers Margin Global Supply enables Val

  16. Slide 16: Valmet has a clear plan to deliver the targeted EUR 100 million savings

    Valmet has a clear plan to deliver the targeted EUR 100 million savings Execution is under way Procurement Footprint Capability Shift to cost-competitive countries Optimization of production footprint Global Supply organization centralized TODAY 37 sites SINCE JULY 2025 TODAY ~80% in EMEA and North

  17. Slide 17: Strong cash conversion track record with growing operating cash flow

    Strong cash conversion track record with growing operating cash flow Cash conversion Operating cash flow, EUR million Average cash conversion EUR million Comparable EBITA, EUR million L10Y 2015–2025: 700 CAGR 2015–2025: 92% Operating cash flow: 22% 600 Comparable EBITA: 13% With EBITA (unadjusted):

  18. Slide 18: Valmet in Q1/2026

    Valmet in Q1/2026 Valmet >

  19. Slide 19: Valmet in Q1/2026

    Valmet in Q1/2026 Orders received Net sales Comparable EBITA (excl. Other) EUR EUR EUR EUR million million EUR EUR million million million million Biomaterial services Biomaterial services EUR 506 million EUR 414 million Orders received Net sales Comparable EBITA Comparable EBITA margin Order backlo

  20. Slide 20: Net sales and Comparable EBITA

    Net sales and Comparable EBITA Net sales (EUR million and organic growth y/y) Comparable EBITA (EUR million and % of net sales) -11% -12% -8% -5% -6% -4% 2% -1% 9% Net sales increased 9% organically Comparable EBITA and margin decreased • Net sales were EUR 60 million higher than in Q1/25 • Comparab

  21. Slide 21: Process Performance Solutions: Q1 margin supported by cost savings

    Process Performance Solutions: Q1 margin supported by cost savings Orders received (EUR million and growth y/y) Q1 2026 performance Orders received increased 4% organically -16% 4% 11% 39% 24% 7% 7% -16% -2% • Similar organic growth in both Automation Solutions and Flow Control Net sales (EUR millio

  22. Slide 22: Biomaterial Solutions and Services: Profitability impacted by sales mix

    Biomaterial Solutions and Services: Profitability impacted by sales mix Orders received (EUR million) Biomaterial services Q1 2026 performance Orders received decreased mainly due to capital project timing • Service orders decreased -7% organically • The decrease in orders received mainly reflects l

  23. Slide 23: Comparable SG&A reflects operating model renewal

    Comparable SG&A reflects operating model renewal Comparable SG&A expenses EUR million and % of net sales Comparable SG&A costs reduction BASELINE EUR 66 million April–June, 2026 © Valmet | Roadshow presentation Q2/2026 LTM = Last twelve months

  24. Slide 24: Guidance and short-term market outlook

    Guidance and short-term market outlook Guidance for 2026 Guidance Valmet reiterates its guidance issued on February 6, 2026, in which Valmet estimates that net sales in 2026 will remain at the previous year's level in comparison with 2025 (EUR 5,197 million) and Comparable EBITA in 2026 will remain

  25. Slide 25: Process Performance Solutions

    Process Performance Solutions

  26. Slide 26: Process Performance Solutions: Mission-critical solutions in customers' core processes

    Process Performance Solutions: Mission-critical solutions in customers’ core processes Mission-critical Diversified and Unique leadership solutions attractive portfolio position in P&P with strong service business of customer industries providing solid base and based on large installed with strong p

  27. Slide 27: Strong positions across diverse industries with 3% annual market growth

    Strong positions across diverse industries with 3% annual market growth Process Performance EUR 16 billion EUR 15 billion Solutions Automation Solutions Flow Control market size Customer Pulp & Marine & Other Refining & Energy & Metals & industry Paper Process Chemicals Gases Mining Automation #1–2

  28. Slide 28: Process Performance Solutions segment in 2025

    Process Performance Solutions segment in 2025 Orders received by industry Orders received by area Orders received by products Orders received EUR 1,500 million 9% Net sales 9% EUR 1,481 million 36% 38% 47% 53% 62% 38% 8% Pulp and Paper North America Flow Control Automation Solutions Other Process In

  29. Slide 29: Flow Control business area in 2025

    Flow Control business area in 2025 Orders received by industry Orders received by area Orders received by products Orders received EUR 798 million 7% Orders received 8% 11% 16% 28% EUR 763 million Net sales 9% EUR 788 million 37% Net sales EUR 791 million Market Position 18% #1 Pulp and Paper 38% Ma

  30. Slide 30: Automation Solutions business area in 2025

    Automation Solutions business area in 2025 Orders received by industry Orders received by area Orders received by products Orders received EUR 702 million 7% 9% 35% 35% Net sales EUR 694 million 46% 50% 50% Market Position #1-2 Pulp and Paper 44% 5% #2-4 Energy and Process* 19% #1-2 Analyzer Prod. &

  31. Slide 31: Biomaterial Solutions and Services

    Biomaterial Solutions and Services

  32. Slide 32: Growing demand increases the need for our Biomaterial Solutions and Services

    Growing demand increases the need for our Biomaterial Solutions and Services Global pulp demand, Mt Global board demand, Mt Global tissue demand, Mt 2% p.a. 2% p.a. 285 265 2% p.a. 245 <1% p.a. 189 171 175 2% p.a. 2% p.a. 40 43 47 2020 2024 F2028 2020 2024 F2028 2020 2024 F2028 Pulp demand growth ac

  33. Slide 33: Valmet is well positioned to capture underlying market growth

    Valmet is well positioned to capture underlying market growth Pulp, Energy and Circularity Packaging and Paper Tissue Pulp Energy Circularity Board Paper Tissue #1–2 #1–3 Strong #1 #1 #1 market position market position innovation market position market position market position track record Services

  34. Slide 34: Biomaterial Solutions and Services segment in 2025

    Biomaterial Solutions and Services segment in 2025 Orders received by BA Orders received by area Orders received by scope Orders received EUR 3,716 million 8% 22% 21% Net sales 13% 31% EUR 3,716 million 41% 52% 10% 27% 37% 39% North America Biomaterial services Pulp, Energy and Latin America Circula

  35. Slide 35: Biomaterial services in 2025

    Biomaterial services in 2025 Orders received by BA Orders received by area Orders received by scope Orders received EUR 1,948 million 12% 10% Net sales 9% 34% 31% EUR 1,856 million 38% 62% 54% 37% 13% North America Pulp, Energy and Latin America Consumables and performance parts Circularity EMEA Pac

  36. Slide 36: Pulp, Energy and Circularity business area in 2025

    Pulp, Energy and Circularity business area in 2025 Orders received by industry Orders received by area Orders received by scope Orders received EUR 1,536 million Orders received 9% EUR 763 million 8% 24% 43% Net sales EUR 1,610 million 38% Net sales 35% EUR 791 million Market Position #1-2 Pulp 11%

  37. Slide 37: Packaging and Paper business area in 2025

    Packaging and Paper business area in 2025 Orders received by industry Orders received by area Orders received by scope Orders received EUR 1,368 million 3% 6% Orders received 8% EUR 763 million Net sales 16% 55% 34% EUR 1,483 million Net sales 25% EUR 791 million Market Position #1-2 Board and Paper

  38. Slide 38: Tissue business area in 2025

    Tissue business area in 2025 Orders received by category Orders received by area Orders received by scope Orders received EUR 812 million Orders received 2% 4% 2% EUR 763 million Net sales 29% EUR 622 million 39% 55% Net sales EUR 791 million 45% 42% Market Position #1 Tissue Market position #1 Pulp

  39. Slide 39: Valmet >

    Valmet >

Valmet — Non-Deal Roadshow (2026) on 6ix